Cargando…
Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
Polyneuropathy with immunoglobulin M (IgM) monoclonal gammopathy is the most common paraproteinemic neuropathy, comprising a clinicopathologically and immunologically distinct entity. The clinical spectrum spans from distal paresthesias and mild gait imbalance to more severe sensory ataxia, with fal...
Autor principal: | Dalakas, Marinos C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791554/ https://www.ncbi.nlm.nih.gov/pubmed/29403542 http://dx.doi.org/10.1177/1756285617746640 |
Ejemplares similares
-
Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy
por: Rakocevic, Goran, et al.
Publicado: (2018) -
Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies
por: Dalakas, Marinos C.
Publicado: (2022) -
Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy
por: Amaador, Karima, et al.
Publicado: (2022) -
Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen‐specific glycopolymer
por: Aliu, Butrint, et al.
Publicado: (2020) -
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions
por: Tsiortou, Popianna, et al.
Publicado: (2021)